Dr. Daniel J. Olson, MD

Dr. Olson practices at Comer Children's Hospital - Hyde Park in Chicago, Illinois.

Dr. Olson's NPI, 1003234329, was assigned on April 3, 2014. Dr. Olson graduated from Rush Medical College of Rush University in 2014. Dr. Olson holds Illinois license 036.142550.

Dr. Olson's primary practice is Comer Children's Hospital - Hyde Park, at 5721 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Dr. Olson's primary practice is Comer Children's Hospital - Hyde Park in Chicago, Illinois. Dr. Olson is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Dr. Olson to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Olson practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Olson's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Olson is board certified in internal medicine by the American Board of Internal Medicine. Dr. Olson is licensed in Illinois.

CMS data shows 637 Medicare services from Dr. Olson across 6 procedure codes in 2024, for 173 Medicare patients. Medicare paid $58,660 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 173 Medicare patients who saw Dr. Olson in 2024. The largest group is 65 to 74, with 82 patients. 75% of them have high blood pressure, and 61% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Olson's median patient age at 70, with 42% women.

In 2024, Dr. Olson wrote 160 Medicare Part D claims for 44 patients. 66% of them were for generic drugs. CMS names the drug for 44 of them, across 2 drugs with 11 or more claims each, at $1,827 in total drug cost. In 2023, CMS named 44 claims across 2 drugs.

Dr. Olson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Olson as offering telehealth.

Dmand AI links 23 papers to Dr. Olson, published from 2011 to 2025. 2023 was the busiest year, with 3. The most frequent topics are Melanoma, Immune Checkpoint Inhibitors and Immunotherapy. Dr. Olson has published most often in Cancers (Basel). Dr. Olson's most frequent co-authors are Jason J. Luke, MD, Thomas F. Gajewski and Brian W. Labadie.

Dmand AI links Dr. Olson to 2 clinical trials. 2 are still active or recruiting. National Cancer Institute (NCI) sponsors the most, 2.

CMS Open Payments shows 19 general payments to Dr. Olson from 9 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 63% of the total. Iovance Biotherapeutics, Inc. paid the most, $6,804.

Dr. Olson graduated from Rush Medical College of Rush University in 2014.